Fmoc-L-Tyr(tBu)-OH
71989-38-3CC(C)(C)Oc1ccc(C[C@H](NC(=O)OCC2c3ccccc3-c3ccccc32)C(=O)O)cc1JAUKCFULLJFBFN-VWLOTQADSA-NSicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
This chemical does not meet GHS hazard criteria for 33.3% (3 of 9) of reports.
Warning
H302 (11.1%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 9 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
VerwendenFmoc-O-tert-butyl-L-tyrosine belongs to L-tyrosine compounds. Its molecular structure contains a chiral center, so it can exist two enantiomers and has optical activity. Fmoc-Tyr(tBu)-OH is used in peptide synthesis as amino acid protection monomer.
synthetischeTo obtain Fmoc-Tyr(tBu)-OH, the following steps are carried out:Suspend O-tert-butyl-L-tyrosine in a solution of dioxane.Conduct an acylation reaction with fluorenyl methaneoxycarbonyl azide.After the reaction, extract the crude product with ethyl acetate under pH 9-10 conditions.Purify the extracted product through recrystallization.This process results in the final product, Fmoc-Tyr(tBu)-OH.
Wird geladen…
71989-38-3DTXSID201315818CHEMBL558872